Recent Finacing
Recent Raise
Crossbow Therapeutics is a biotechnology company developing TCR-mimetic (T-Bolt™) antibody T-cell engager therapies that target peptide–HLA complexes on cancer cells.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Crossbow Therapeutics.